MAR 20, 2014 12:00 PM PDT

The potential of robotic technology as a next generation technology for neurological assessment

Presented at: Neuroscience
Speaker
  • Professor Department of Biomedical and Molecular Sciences, Queens University School of Medicine
    Biography
      Dr. Stephen Scott is a professor in the Department of Biomedical and Molecular Sciences at Queen's University. He is also a member of the Centre for Neuroscience Studies and the CIHR Group in Sensory-Motor Systems. He graduated from the University of Waterloo in Systems Designs Engineering for his undergraduate degree and a M.A.Sc. with Dr. D.A. Winter. He then did a Ph.D. with Dr. Gerry Loeb at Queens University in the Department of Physiology. After that he went to the Universit de Montral for his postdoctoral training in the Department of Physiology with Dr. John Kalaska from 1993 to 1995. His first faculty position was as a chercheur adjoint in the Department of Physiology at Universit de Montral in 1995. He moved his lab to Queen's University in 1997.

    Abstract

    Assessment of sensorimotor and cognitive function plays a crucial role in all facets of patient care, from diagnosing the specific disease or injury, to management and monitoring of rehabilitation strategies to ameliorate dysfunction. Most assessment scales for sensorimotor function are subjective in nature with relatively coarse rating systems, reflecting that it is difficult for even an experienced observer to discriminate small changes in performance using only the naked eye. Robotic technologies have had a profound impact in basic research to understand fundamental properties of sensorimotor control due to their ability to control the position or forces applied to the limb and their inherent ability to objectively quantify motor behavior. Our general hypothesis is that these same attributes make robotic technologies ideal for creating a new approach to neurological assessment. I will discuss a number of novel robot-based tasks weve developed to assess brain function in subjects with stroke, highlighting the complex patterns of sensory, motor and cognitive deficits that can be quantified with this technology.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources